-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades Vigil Neuroscience to Neutral, Lowers Price Target to $8

Benzinga·05/27/2025 15:25:47
Listen to the news
HC Wainwright & Co. analyst Andrew Fein downgrades Vigil Neuroscience (NASDAQ:VIGL) from Buy to Neutral and lowers the price target from $14 to $8.